153 related articles for article (PubMed ID: 11096440)
1. Self-selection by genetically modified committed lymphocyte precursors reverses the phenotype of JAK3-deficient mice without myeloablation.
Bunting KD; Lu T; Kelly PF; Sorrentino BP
Hum Gene Ther; 2000 Nov; 11(17):2353-64. PubMed ID: 11096440
[TBL] [Abstract][Full Text] [Related]
2. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer.
Bunting KD; Sangster MY; Ihle JN; Sorrentino BP
Nat Med; 1998 Jan; 4(1):58-64. PubMed ID: 9427607
[TBL] [Abstract][Full Text] [Related]
3. Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency.
Bunting KD; Flynn KJ; Riberdy JM; Doherty PC; Sorrentino BP
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):232-7. PubMed ID: 9874801
[TBL] [Abstract][Full Text] [Related]
4. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction.
Candotti F; Oakes SA; Johnston JA; Notarangelo LD; O'Shea JJ; Blaese RM
J Exp Med; 1996 Jun; 183(6):2687-92. PubMed ID: 8676091
[TBL] [Abstract][Full Text] [Related]
5. Reconstitution of lymphoid development and function in ZAP-70-deficient mice following gene transfer into bone marrow cells.
Otsu M; Steinberg M; Ferrand C; Merida P; Rebouissou C; Tiberghien P; Taylor N; Candotti F; Noraz N
Blood; 2002 Aug; 100(4):1248-56. PubMed ID: 12149205
[TBL] [Abstract][Full Text] [Related]
6. In vivo retroviral gene transfer by direct intrafemoral injection results in correction of the SCID phenotype in Jak3 knock-out animals.
McCauslin CS; Wine J; Cheng L; Klarmann KD; Candotti F; Clausen PA; Spence SE; Keller JR
Blood; 2003 Aug; 102(3):843-8. PubMed ID: 12689938
[TBL] [Abstract][Full Text] [Related]
7. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of early lymphoid proliferation and immune function in Jak3-deficient mice by interleukin-3.
Brown MP; Nosaka T; Tripp RA; Brooks J; van Deursen JM; Brenner MK; Doherty PC; Ihle JN
Blood; 1999 Sep; 94(6):1906-14. PubMed ID: 10477719
[TBL] [Abstract][Full Text] [Related]
9. Unexpected and variable phenotypes in a family with JAK3 deficiency.
Frucht DM; Gadina M; Jagadeesh GJ; Aksentijevich I; Takada K; Bleesing JJ; Nelson J; Muul LM; Perham G; Morgan G; Gerritsen EJ; Schumacher RF; Mella P; Veys PA; Fleisher TA; Kaminski ER; Notarangelo LD; O'Shea JJ; Candotti F
Genes Immun; 2001 Dec; 2(8):422-32. PubMed ID: 11781709
[TBL] [Abstract][Full Text] [Related]
10. Jak3 and the pathogenesis of severe combined immunodeficiency.
O'Shea JJ; Husa M; Li D; Hofmann SR; Watford W; Roberts JL; Buckley RH; Changelian P; Candotti F
Mol Immunol; 2004 Jul; 41(6-7):727-37. PubMed ID: 15220007
[TBL] [Abstract][Full Text] [Related]
11. T cells from Jak3-deficient mice have intact TCR signaling, but increased apoptosis.
Thomis DC; Lee W; Berg LJ
J Immunol; 1997 Nov; 159(10):4708-19. PubMed ID: 9366394
[TBL] [Abstract][Full Text] [Related]
12. Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the gamma-c gene.
Taylor N; Uribe L; Smith S; Jahn T; Kohn DB; Weinberg K
Blood; 1996 Apr; 87(8):3103-7. PubMed ID: 8605323
[TBL] [Abstract][Full Text] [Related]
13. [Long-term expansion of T cell progenitors by JAK3 gene transduced primitive hematopoietic cells in vitro].
Zhao SM; Gu XC; Chang NB; Xu XD; Peng MT
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1701-5. PubMed ID: 16854326
[TBL] [Abstract][Full Text] [Related]
14. In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer.
Adjali O; Marodon G; Steinberg M; Mongellaz C; Thomas-Vaslin V; Jacquet C; Taylor N; Klatzmann D
J Clin Invest; 2005 Aug; 115(8):2287-95. PubMed ID: 16075064
[TBL] [Abstract][Full Text] [Related]
15. Development of autologous, oligoclonal, poorly functioning T lymphocytes in a patient with autosomal recessive severe combined immunodeficiency caused by defects of the Jak3 tyrosine kinase.
Brugnoni D; Notarangelo LD; Sottini A; Airò P; Pennacchio M; Mazzolari E; Signorini S; Candotti F; Villa A; Mella P; Vezzoni P; Cattaneo R; Ugazio AG; Imberti L
Blood; 1998 Feb; 91(3):949-55. PubMed ID: 9446656
[TBL] [Abstract][Full Text] [Related]
16. A new chance for SCID gene therapy.
Bordignon C
Nat Med; 1998 Jan; 4(1):19-20. PubMed ID: 9427599
[No Abstract] [Full Text] [Related]
17. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.
Park SY; Saijo K; Takahashi T; Osawa M; Arase H; Hirayama N; Miyake K; Nakauchi H; Shirasawa T; Saito T
Immunity; 1995 Dec; 3(6):771-82. PubMed ID: 8777722
[TBL] [Abstract][Full Text] [Related]
18. Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency.
Notarangelo LD; Mella P; Jones A; de Saint Basile G; Savoldi G; Cranston T; Vihinen M; Schumacher RF
Hum Mutat; 2001 Oct; 18(4):255-63. PubMed ID: 11668610
[TBL] [Abstract][Full Text] [Related]
19. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.
Hacein-Bey-Abina S; Le Deist F; Carlier F; Bouneaud C; Hue C; De Villartay JP; Thrasher AJ; Wulffraat N; Sorensen R; Dupuis-Girod S; Fischer A; Davies EG; Kuis W; Leiva L; Cavazzana-Calvo M
N Engl J Med; 2002 Apr; 346(16):1185-93. PubMed ID: 11961146
[TBL] [Abstract][Full Text] [Related]
20. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.
Russell SM; Tayebi N; Nakajima H; Riedy MC; Roberts JL; Aman MJ; Migone TS; Noguchi M; Markert ML; Buckley RH; O'Shea JJ; Leonard WJ
Science; 1995 Nov; 270(5237):797-800. PubMed ID: 7481768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
